<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996954</url>
  </required_header>
  <id_info>
    <org_study_id>IRAS Project ID:245687</org_study_id>
    <nct_id>NCT03996954</nct_id>
  </id_info>
  <brief_title>Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias</brief_title>
  <official_title>Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Blackpool Teaching Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Blackpool Teaching Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will evaluate the diagnostic yield of the new AliveCor device versus a 12
      lead ECG when used simultaneously to detect cardiac arrhythmia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are planning to record 250 pre-defined abnormal ECGs (50 each of atrial
      fibrillation, atrial flutter, pre-excitation, ventricular tachycardia, , supraventricular
      tachycardia) and 150 control ECGs (100 sinus rhythm, 50 sinus tachycardia) using both the
      AliveCor Smartphone device and a 12-lead ECG. All 400 ECGs will then be read by 3 blinded
      reporters - a Consultant Electrophysiologist, a Consultant General Cardiologist and a General
      Practitioner. The output of the AliveCor automatic detection algorithm will also be recorded
      as a fourth reporter. The screening characteristics of all 4 reporters using the AliveCor
      device vs the definitive 12 lead ECG will be analysed and compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 8, 2018</start_date>
  <completion_date type="Anticipated">October 7, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 7, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Recordings with Alivecor and 12 lead ECGs with be acquired from patients with known arrhythmias/normal heart rhythm and blinded physicians will report on recordings and ECGs. Reports for each patient will be compared at the end of the study in order to assess diagnostic accuracy of the Alivecor to detect and differentiate between different kinds of abnormal heart rhythms.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of alivecor recording</measure>
    <time_frame>Diagnostic accuracy of Alivecor recording at the end of the study which will be 2 years after study start date.</time_frame>
    <description>For each patient two diagnoses of their underlying heart rhythm will be provided by blinded reporters. The percentage match of these diagnoses (the ratio of identical diagnoses to mismatch in diagnoses between ECG report and Alivecor report will be used as a measure of accuracy of the Alivecor to differentiate between different heart rhythms, using the 12 lead ECG as the gold standard for cardiac rhythm diagnosis.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cardiac Arrhythmia</condition>
  <arm_group>
    <arm_group_label>Normal ECGs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with normal ECGs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abnormal ECGs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with different kinds of abnormal heart rhythms will be enrolled in order to compare whether Alivecor can accurately differentiate between these abnormal heart rhythms and normal sinus rhythm/sinus tachycardia. Also, Alivecor diagnostic accuracy in differentiating between different kinds of arrhythmias will be assessed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alivecor recording</intervention_name>
    <description>Alivecor recording and ECG recording from the same patient in very close temporal proximity</description>
    <arm_group_label>Abnormal ECGs</arm_group_label>
    <arm_group_label>Normal ECGs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patients &gt;18 years

          -  12 lead ECG finding of arrhythmia, manifest pre-excitation, pacing rhythm (in the EP
             lab), sinus rhythm or sinus tachycardia

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Patients unable to or unwilling to use the device

          -  Patients with cardiac pacemaker, ICDs, or other implanted electronic devices
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid Abozguia, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Blackpool Teaching Hospitals NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khalid Abozguia, Ph.D.</last_name>
    <phone>00441253957780</phone>
    <email>k.abozguia@nhs.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dimitrios Katsaras, MD</last_name>
    <phone>00441253957780</phone>
    <email>d.katsaras@nhs.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Blackpool Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Blackpool</city>
        <state>Lancashire</state>
        <zip>FY3 8NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khalid Abozguia, PhD</last_name>
      <phone>00441253957780</phone>
      <email>k.abozguia@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Dimitrios Katsaras, MD</last_name>
      <phone>00441253957780</phone>
      <email>d.katsaras@nhs.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>June 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>June 22, 2019</last_update_submitted>
  <last_update_submitted_qc>June 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Blackpool Teaching Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Dr. Khalid Abozguia</investigator_full_name>
    <investigator_title>Consultant Cardiologist and Electrophysiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 27, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT03996954/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

